Editorial
doi: 10.1111/j.1742-1241.2009.02233.x.
Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones
- PMID: 20089004
- DOI: 10.1111/j.1742-1241.2009.02233.x
Item in Clipboard
Editorial
Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones
Int J Clin Pract.
2010 Jan.
No abstract available
Comment on
-
The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*.Int J Clin Pract. 2010 Jan;64(2):169-81. doi: 10.1111/j.1742-1241.2009.02196.x. Int J Clin Pract. 2010. PMID: 20089007 Review.
Similar articles
-
Drug treatment and cost of cardiovascular disease in Australia.Cardiovasc Ther. 2009 Fall;27(3):164-72. doi: 10.1111/j.1755-5922.2009.00090.x. Cardiovasc Ther. 2009. PMID: 19689615
-
ACE inhibitors: back to prime time?Heart. 2007 Sep;93(9):1015-6. doi: 10.1136/hrt.2006.108100. Heart. 2007. PMID: 17699166 Free PMC article.
-
[The elderly cardiovascular patient in general practice. Health care costs--drugs--economic feasibility].Fortschr Med. 1996 Mar 10;114(7):43-4. Fortschr Med. 1996. PMID: 8900969 German. No abstract available.
-
The cost effectiveness of cardiovascular medicines.Curr Atheroscler Rep. 2005 Mar;7(2):79-80. doi: 10.1007/s11883-005-0026-0. Curr Atheroscler Rep. 2005. PMID: 15727719 Review. No abstract available.
-
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Role of economic models in randomized clinical trials.Am Heart J. 1999 May;137(5):S41-6. doi: 10.1016/s0002-8703(99)70427-8. Am Heart J. 1999. PMID: 10220595 Review. No abstract available.
Cited by
-
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.Cochrane Database Syst Rev. 2017 Apr 5;4(4):CD008600. doi: 10.1002/14651858.CD008600.pub3. Cochrane Database Syst Rev. 2017. PMID: 28378924 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources